HR 1878 creates a new federal tax credit for out-of-pocket expenses related to fertility treatments like IVF. It allows eligible taxpayers to claim a credit equal to up to $20,000 per year (or $40,000 for joint filers) for qualifying expenses, subject to income limits ($200,000 AGI for individuals, $400,000 for couples). The credit phases out for taxpayers earning above these thresholds and cannot be claimed for expenses covered by insurance or other deductions. This directly affects individuals and couples seeking fertility treatments who pay for them out-of-pocket.
HR 2426 requires the VA Secretary to commission an independent study comparing the quality of mental health and addiction care provided by VA health care providers versus non-VA providers for veterans. The study must examine health outcomes, use of proven treatment methods, care coordination, veteran satisfaction, and access times across different care types like telehealth and in-person visits. It mandates a report to Congress and public release within 18 months, detailing findings on factors like symptom improvement, suicide risk assessment, and whether veterans with multiple conditions receive integrated care. This bill directly affects veterans seeking mental health or addiction therapy services and aims to identify gaps in care quality between VA and non-VA systems.
This bill, S 2770 (Share the Savings with Seniors Act), changes Medicare Part D drug coverage for seniors taking specific chronic medications. It requires that for covered chronic care drugs (like blood glucose regulators, anticoagulants, and certain inhalers), beneficiaries pay no more than the drug’s actual negotiated price (net price) for costs below the deductible, and coinsurance above the deductible must be based on that net price. The rules apply to plan years starting January 1, 2027, directly affecting Medicare Part D enrollees using drugs in the defined categories. The bill clarifies that cost-sharing for these drugs cannot exceed the negotiated price, aiming to reduce out-of-pocket costs for seniors on long-term medications.
S 2699, the Geriatrics Workforce Improvement Act, authorizes $48,245,000 annually for fiscal years 2026 through 2030 to fund geriatrics education and training programs under the Public Health Service Act. This funding directly supports healthcare providers and training institutions focused on elder care by expanding resources for developing geriatric specialists. The bill’s key provision replaces a prior funding reference with this specific, multi-year appropriation to strengthen the geriatric healthcare workforce. It does not change eligibility or create new requirements, only establishing dedicated federal funding for existing geriatrics training initiatives.
This bill amends the 21st Century Cures Act to explicitly include fentanyl and xylazine test strips in grant funding for state and tribal programs addressing opioid use disorders. It directly affects state and tribal health agencies that receive federal grants under this program by expanding eligibility to cover these specific test strips. The key provision adds "fentanyl or xylazine test strips" to the list of approved items that grant funds may support, ensuring these critical tools for detecting dangerous substances are included in funding. The change updates existing grant language without creating new requirements or altering program administration.
This bill, S 36 (Protect Our Seniors Act), adds procedural rules to prevent the Senate from considering bills that would reduce Medicare (Title XVIII) or Social Security (Title II) benefits. It creates a "point of order" that would block such legislation unless waived by a two-thirds vote of the Senate. A separate provision also blocks bills using Medicare program cuts to offset costs for other provisions, requiring the same two-thirds waiver. The bill directly affects how the Senate handles budget-related bills impacting senior benefit programs.
The Providing Veterans Essential Medications Act requires the Department of Veterans Affairs to reimburse State homes or provide medications directly for certain high-cost drugs used by veterans in State-run nursing homes. A medication is defined as high-cost if its price (including a 3% fee) exceeds 8.5% of the VA's monthly payment for the veteran's care at that home. This applies specifically to State homes that provide such medications to veterans under VA contracts. The bill ensures veterans receive essential medications without financial burden on the State homes, using clear cost thresholds to determine eligibility.
S 2371, the Safe Baby Formula Act of 2025, requires the U.S. Department of Health and Human Services (HHS) to study the health impacts of arsenic, cadmium, mercury, and lead in infant formula within one year of enactment. Within 90 days of the bill becoming law, HHS must establish either enforceable action levels or formal maximum contamination limits for these toxic metals in infant formula. The bill directly affects infant formula manufacturers and distributors, who will need to comply with the new safety standards. The law defines "infant formula" using the existing federal definition under the Federal Food, Drug, and Cosmetic Act.
This bill requires Medicare drug plan sponsors and Medicare Advantage plans to pay long-term care pharmacies (pharmacies serving nursing homes and assisted living facilities) a mandatory $30 supply fee per prescription in 2026, increasing annually in 2027 based on inflation. The fee must be paid separately from existing reimbursements for drug costs or dispensing, and sponsors face $10,000 penalties for non-payment. The government will later reimburse sponsors for these fees through subsidies, paid within 18 months after each plan year. The bill also directs a GAO study on pharmacy payment sustainability in Medicare Part D, focusing on rural access and cost analysis. It directly affects long-term care pharmacies and Medicare drug plan sponsors, aiming to ensure uninterrupted pharmacy services for nursing home residents.
HR 6728, the Linking Seniors to Needed Legal Services Act of 2025, provides $125 million annually (2026-2029) to fund state grants that connect vulnerable seniors to legal services through healthcare settings. It directly affects seniors facing legal issues impacting health (like housing or elder abuse) by establishing medical-legal partnerships in clinics, hospitals, and community health centers. Key provisions include funding for legal hotlines, partnerships between healthcare providers and lawyers, and requiring states to report on referral success rates and issue resolution times. The bill aims to address social determinants of health by embedding legal support within existing health services for seniors.
